Glipizide
- Product NDC
- 70934-843
- 11-digit product format
- 709340843
- Labeler code
- 70934
- Product ID
- 70934-843_c2144b56-6903-d987-e053-2a95a90a9709
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA206928
- Marketing category
- ANDA
- Marketing start
- 2021-03-16
- Marketing end
- 0000-00-00
- Substance
- GLIPIZIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Sulfonylurea [EPC],Sulfonylurea Compounds [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-843-30 | 70934084330 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-843-30) | 2021-03-16 | 0000-00-00 | No | No | Current |
| 70934-843-90 | 70934084390 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-843-90) | 2021-05-04 | 0000-00-00 | No | No | Current |